Biography
Luc began his career at Bankers Trust, as Vice-President and Regional Sales Manager, Northern Europe. He was a Board Director of Schroders plc from 2006 until 2015. He has been with Ackermans & van Haaren as a director since 1985, where he joined as financial director in 1986 and was chairman of the executive committee from 1990 to 2016. He is chairman of the board of directors of CFE, DEME and SIPEF and a director of Delen Private Bank, JM Finn, Bank J.Van Breda & C° and Verdant Bioscience. He is also chairman of the Duve Institute and Middelheim Promoters, member of a number of other boards of directors of non-profit associations and public institutions, such as Museum Mayer van den Bergh and Europalia, member of the board of trustees of Guberna and member of the general board of the Institute of Tropical Medicine. He has served as a NED on our Board since 2011 and became Chairman in 2024.
At the mid-point of 2026 and also the World Cup, Andrew Mann gives an overview of how UK stocks are faring in comparison to others on the global stage.
Head of Investment Office Jon Cunliffe explains why the late former US Federal Reserve Chair’s policy of ‘constructive ambiguity’ has once again become de rigueur with Fed leaders.
Following the successful IPO of SpaceX, a new class of wealth has emerged, writes Investment Director Andrew Mann.